14 pioneering startups are selected for the 2025 CancerX Accelerator
CancerX posted on LinkedIn:
“Announcing the 2025 CancerX Accelerator Cohort!
We are thrilled to introduce the 14 pioneering startups selected for the 2025 CancerX Accelerator, a national innovation platform designed to accelerate digital solutions in the fight against cancer. These game-changing companies are tackling critical challenges in clinical research, diagnostics, treatment, clinical operations, and patient/caregiver experiences – all with the goal of reducing cancer death rates and improving lives.
These innovative companies will work closely with our Accelerator Champions (and others) to fast-track their solutions and create lasting impact.
We’re excited to see how these startups drive change, and we can’t wait to follow their journey as they work to transform the future of cancer care.
Stay tuned for updates and be part of the movement to revolutionize oncology with CancerX Accelerator!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023